NasdaqCM - Nasdaq Real Time Price USD
HOOKIPA Pharma Inc. (HOOK)
1.2800
-0.0600
(-4.48%)
At close: May 5 at 4:00:00 PM EDT
1.3426
+0.06
+(4.89%)
Pre-Market: 8:37:33 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
43,946
43,946
20,129
14,249
18,448
Operating Expense
81,337
81,337
93,864
79,488
90,398
Operating Income
-37,391
-37,391
-73,735
-65,239
-71,950
Net Non Operating Interest Income Expense
3,699
3,699
4,976
946
-871
Other Income Expense
-9,917
-9,917
-12,453
-392
-2,843
Pretax Income
-43,609
-43,609
-81,212
-64,685
-75,664
Tax Provision
-106
-106
368
230
1
Net Income Common Stockholders
-43,503
-43,503
-81,580
-64,915
-75,665
Diluted NI Available to Com Stockholders
-43,503
-43,503
-81,580
-64,915
-75,665
Basic EPS
-3.47
--
-8.63
-9.91
-23.00
Diluted EPS
-3.47
--
-8.63
-9.91
-23.00
Basic Average Shares
12,538.7940
--
9,452.6570
6,551.2960
6,558.0800
Diluted Average Shares
12,538.7940
--
9,452.6570
6,551.2960
6,558.0800
Total Operating Income as Reported
-51,455
-51,455
-97,694
-73,155
-81,674
Total Expenses
81,337
81,337
93,864
79,488
90,398
Net Income from Continuing & Discontinued Operation
-43,503
-43,503
-81,580
-64,915
-75,665
Normalized Income
-36,851.2078
-36,851.2078
-68,877.8300
-64,915
-75,665
Interest Income
3,701
3,701
5,293
1,633
27
Interest Expense
2
2
317
687
898
Net Interest Income
3,699
3,699
4,976
946
-871
EBIT
-43,607
-43,607
-80,895
-63,998
-74,766
EBITDA
-40,854
-40,854
-77,343
-60,396
-70,126
Reconciled Depreciation
2,753
2,753
3,552
3,602
4,640
Net Income from Continuing Operation Net Minority Interest
-43,503
-43,503
-81,580
-64,915
-75,665
Total Unusual Items Excluding Goodwill
-6,668
-6,668
-12,766
--
--
Total Unusual Items
-6,668
-6,668
-12,766
--
--
Normalized EBITDA
-34,186
-34,186
-64,577
-60,396
-70,126
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
-16.2078
-16.2078
-63.8300
--
--
12/31/2021 - 4/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATNF 180 Life Sciences Corp.
1.0800
-10.00%
INZY Inozyme Pharma, Inc.
1.4900
-8.02%
FULC Fulcrum Therapeutics, Inc.
5.73
+1.96%
ADIL Adial Pharmaceuticals, Inc.
0.6895
+2.91%
LXEO Lexeo Therapeutics, Inc.
4.4500
-4.09%
GOSS Gossamer Bio, Inc.
1.2500
+5.93%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2989
+18.99%
IBO Impact BioMedical Inc.
0.6000
-19.79%
SPRC SciSparc Ltd.
0.4000
+38.41%
PRQR ProQR Therapeutics N.V.
1.8000
-9.55%